Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Hans Lilja
Icahn School of Medicine at Mount Sinai, Department: Genetics
Should you be removed from our database? Contact us at [email protected]. Read more below.
OPKO Health
Intellectual property rights (e.g., royalties, patents, copyrights) not from the awardee Institution
The overall objective of the grant is to determine if consideration of an individual’s genetic makeup can improve the accuracy of screening tests based on PSA and other prostate-produced biomarkers. The outcome of the research could affect the value of the inventions. Because of the potential for future royalties in the event that the research demonstrates the value of the markers and algorithm, MSKCC has determined that an FCOI exists.
Improving prostate cancer screening by integration of SNPs with blood biomarkers
While measurements of levels of the prostate-specific antigen (PSA) in the blood of healthy men is routinely used to screen for prostate cancer, this test is les than ideal as elevated levels of PSA result in many men undergoing needless prostate biopsies that reveal no cancer. To reduce the number of unnecessary biopsies conducted, a method of integrating genetic information with blood levels of PSA and related proteins will be developed under this grant. This method will enable early prostate cancer to still be detected while reducing the number of men without cancer who undergo needless biopsies.
Filed on November 20, 2015.
Tell us what you know about Hans Lilja's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Hans Lilja”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Hans Lilja | Sloan Kettering Inst Can Research | Conflict of Interest | OPKO Health | $10,000 - $19,999 |
| Hans Lilja | Sloan Kettering Inst Can Research | Conflict of Interest | OPKO Health | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.